- Home
- LGVN vs IVDA Comparison
LGVN vs IVDA Comparison
Compare LGVN & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LGVN | IVDA |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4M | 3.7M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LGVN | IVDA |
|---|---|---|
| Price | $2.59 | $0.30 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $61.25 | N/A |
| AVG Volume (30 Days) | 138.4K | ★ 311.9K |
| Earning Date | 11-03-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.76 | ★ 51.38 |
| EPS | N/A | ★ N/A |
| Revenue | $709,000.00 | ★ $4,468,279.00 |
| Revenue This Year | $46.15 | N/A |
| Revenue Next Year | $396.46 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 132.98 |
| 52 Week Low | $0.48 | $0.21 |
| 52 Week High | $7.60 | $2.15 |
Technical Indicators
Market Signals| Indicator | LGVN | IVDA |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 48.72 |
| Support Level | $0.61 | $0.27 |
| Resistance Level | $7.45 | $0.33 |
| Average True Range (ATR) | 0.34 | 0.02 |
| MACD | -0.36 | 0.00 |
| Stochastic Oscillator | 7.92 | 34.02 |
Price Performance
Historical ComparisonAbout LGVN Longeveron Inc.
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.